Type of hormone therapy and risk of misclassification at mammography screening

Sisse Helle Njor; Jesper Hallas; Walter Schwartz; Elsebeth Lynge; Anette Tønnes Pedersen

doi:10.1097/gme.0b013e3181ea1fd5

Type of hormone therapy and risk of misclassification at mammography screening

Sisse Helle Njor, Jesper Hallas, Walter Schwartz, Elsebeth Lynge, Anette Tønnes Pedersen

9 Citationer (Scopus)

Abstract

Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.

Originalsprog	Engelsk
Tidsskrift	Menopause (New York, N.Y.)
Vol/bind	18
Udgave nummer	2
Sider (fra-til)	171-7
Antal sider	7
DOI	https://doi.org/10.1097/gme.0b013e3181ea1fd5
Status	Udgivet - 1 feb. 2011

Adgang til dokumentet

10.1097/gme.0b013e3181ea1fd5

Citationsformater

@article{194b058d43474f5c96e25fb9cdd49800,

title = "Type of hormone therapy and risk of misclassification at mammography screening",

abstract = "Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.",

author = "Njor, {Sisse Helle} and Jesper Hallas and Walter Schwartz and Elsebeth Lynge and Pedersen, {Anette T{\o}nnes}",

year = "2011",

month = feb,

day = "1",

doi = "10.1097/gme.0b013e3181ea1fd5",

language = "English",

volume = "18",

pages = "171--7",

journal = "Menopause (New York, N.Y.)",

issn = "1530-0374",

publisher = "Wolters Kluwer Health",

number = "2",

}

TY - JOUR

T1 - Type of hormone therapy and risk of misclassification at mammography screening

AU - Njor, Sisse Helle

AU - Hallas, Jesper

AU - Schwartz, Walter

AU - Lynge, Elsebeth

AU - Pedersen, Anette Tønnes

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.

AB - Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.

U2 - 10.1097/gme.0b013e3181ea1fd5

DO - 10.1097/gme.0b013e3181ea1fd5

M3 - Journal article

C2 - 20729766

SN - 1530-0374

VL - 18

SP - 171

EP - 177

JO - Menopause (New York, N.Y.)

JF - Menopause (New York, N.Y.)

IS - 2

ER -

Type of hormone therapy and risk of misclassification at mammography screening

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater